| Name | ZMC1 |
| Description | NSC-319726 (ZMC1), a mutant p53R175 reactivator, suppresses growth of fibroblasts that expresses the p53R175 mutation (IC50 = 8 nM). |
| Cell Research | Viability assays are done. The cells (5×104 cells/well, in 1 ml culture) are cultured in a 12-well plate to reach the 50%–60% confluence on the second day when treated with serial dilutions of the compound. The growth is measured by Guava ViaCount reagent and Guava PCA instrument after incubation for 3 days.(Only for Reference) |
| Kinase Assay | MTS: 5,000 cells of TOV112D cells (5,000 cells/well, in 100 ml culture) are cultured in 96-well plate to reach the 50%–60% confluence on the second day when treated with serial dilutions of the compounds. The growth is measured by MTS reagent and Victor Plate reader instrument after incubation for 3 days. |
| In vitro | In cells with mutant p53, NSC319726 (IC50=8 nM) causes a WT-like conformational change in the mutant protein that repairs sequence-specific p53 transcription. |
| In vivo | In cells with mutant p53, NSC319726 (IC50=8 nM) causes a WT-like conformational change in the mutant protein that repairs sequence-specific p53 transcription. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | Ethanol : 2.3 mg/mL (10 mM)), Heating is recommended.
DMSO : 23.4 mg/mL (100 mM)
|
| Keywords | NSC 319726 | MDM-2/p53 | inhibit | ZMC 1 | ZMC-1 | NSC-319726 | NSC319726 | Inhibitor |
| Inhibitors Related | Rotenone | XI-006 | DPBQ | Roslin 2 bromide | BAY 1892005 | Indole-3-carbinol | Magnolol | RITA | P53R3 | CT-1 |
| Related Compound Libraries | Ferroptosis Compound Library | Glycometabolism Compound Library | Bioactive Compound Library | Glutamine Metabolism Compound Library | Autophagy Compound Library | Stem Cell Differentiation Compound Library | NO PAINS Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library |
United States
